Verrica Pharmaceuticals Correlations

VRCA Stock  USD 0.47  0.05  8.85%   
The correlation of Verrica Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Verrica Pharmaceuticals Correlation With Market

Average diversification

The correlation between Verrica Pharmaceuticals and DJI is 0.13 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Verrica Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verrica Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
For information on how to trade Verrica Stock refer to our How to Trade Verrica Stock guide.

Moving together with Verrica Stock

  0.63ELEV Elevation OncologyPairCorr
  0.73KRON Kronos BioPairCorr

Moving against Verrica Stock

  0.59OCX OncoCyte CorpPairCorr
  0.51BMY Bristol Myers SquibbPairCorr
  0.48SNY Sanofi ADRPairCorr
  0.46AZN AstraZeneca PLC ADRPairCorr
  0.46GILD Gilead Sciences Potential GrowthPairCorr
  0.32GOSS Gossamer BioPairCorr
  0.51AMGN Amgen IncPairCorr
  0.42NVCT Nuvectis PharmaPairCorr
  0.31DRMAW Dermata TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
NUVBABOS
VRNAIVA
ABOSCNTB
NUVBCNTB
VRNAVIGL
ETONVIGL
  
High negative correlations   
VRNAABOS
VRNANUVB
NUVBIVA
ABOSIVA
CNTBIVA
VRNACNTB

Risk-Adjusted Indicators

There is a big difference between Verrica Stock performing well and Verrica Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Verrica Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
LIAN  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
IVA  2.98  0.41  0.10  0.37  3.37 
 5.84 
 23.67 
EWTX  2.65 (0.40) 0.00 (0.31) 0.00 
 4.89 
 17.09 
VIGL  3.85  0.21  0.03  0.08  5.00 
 7.87 
 27.97 
CNTB  3.50 (0.33) 0.00 (0.37) 0.00 
 7.59 
 29.84 
ABOS  3.02 (0.59) 0.00 (0.49) 0.00 
 6.57 
 19.77 
ETON  3.59  0.36  0.08  0.34  4.26 
 7.74 
 25.22 
NUVB  3.33 (0.34) 0.00 (0.48) 0.00 
 6.88 
 28.03 
ELDN  2.75 (0.22) 0.00 (0.18) 0.00 
 4.71 
 18.63 
VRNA  3.06  0.76  0.24  1.44  2.87 
 7.76 
 17.34 

Verrica Pharmaceuticals Corporate Management

Eugene ScavolaExecutive OperationsProfile
Terence KohlerChief OfficerProfile
Dr MBAHead DevelopmentProfile
Christopher HayesSecretary, OfficerProfile
Joe BonaccorsoChief Commercial OfficerProfile
Gary MDChief OfficerProfile
David ZawitzChief OfficerProfile